Article
A controlled study of nitazoxanide (NTZ) 3 years after treatment of hepatitis C genotype 4.
Journal of the Egyptian Society of Parasitology - 1 Aug 2011
Kabil S M, Soliman M S, Youssef S M, Mounier B I
Abstract excerpt
This study is an extension of an earlier, randomized; placebo-controlled that showed the efficacy of nitazoxanide (NTZ) 500 mg tablets twice daily for 6 months in treating HCV genotype 4. Access was available to 13/32 patients of the original study with chronic HCV during more than 3 years after the study was finished. One patient (with portal hypertension and oesophageal varices "O.V") was among 3 with SVR out...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.